The ESMO Clinical Practice Guidelines on Lung Cancer cover early-stage and locally advanced (non-metastatic) NSCLC, Metastatic NSCLC, and more. Small-Cell Lung Cancer · Early-Stage and Locally... · Non-Oncogene-Addicted... |
These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship. Also ... |
The guideline covers diagnosis, staging, risk assessment, treatment and disease monitoring. ESMO-MCBS scores are given to describe the levels of evidence for ... |
This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene addicted mNSCLC. The guideline covers diagnosis, ... |
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · This ESMO Clinical Practice Guideline provides key ... |
ESMO Consensus Guidelines: Early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Lung and Chest Tumours. |
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ... Carcinoembryonic antigen (CEA) as tumor marker ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |